BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28602044)

  • 1. The dynamic interaction between pain and opioid misuse.
    Wilson-Poe AR; MorĂ³n JA
    Br J Pharmacol; 2018 Jul; 175(14):2770-2777. PubMed ID: 28602044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid research in the time of the opioid crisis.
    Traynor JR; Moron JA
    Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
    Varga BR; Streicher JM; Majumdar S
    Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
    Gasior M; Bond M; Malamut R
    Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
    Webster LR; Markman J; Cone EJ; Niebler G
    Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
    Gaborit M; Massotte D
    Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
    Cao DN; Li F; Wu N; Li J
    Br J Pharmacol; 2023 Apr; 180(7):862-878. PubMed ID: 34128238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opioid crisis: a 21st century pain.
    Walker G
    Drugs Today (Barc); 2018 Apr; 54(4):283-286. PubMed ID: 29869649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
    Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
    Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of opioids on immune function in patients with cancer pain: from bench to bedside.
    Boland JW; Pockley AG
    Br J Pharmacol; 2018 Jul; 175(14):2726-2736. PubMed ID: 28593737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.
    Turk DC; O'Connor AB; Dworkin RH; Chaudhry A; Katz NP; Adams EH; Brownstein JS; Comer SD; Dart R; Dasgupta N; Denisco RA; Klein M; Leiderman DB; Lubran R; Rappaport BA; Zacny JP; Ahdieh H; Burke LB; Cowan P; Jacobs P; Malamut R; Markman J; Michna E; Palmer P; Peirce-Sandner S; Potter JS; Raja SN; Rauschkolb C; Roland CL; Webster LR; Weiss RD; Wolf K
    Pain; 2012 Oct; 153(10):1997-2008. PubMed ID: 22770841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Opioid Abuse and Treatment of Opioid Addiction: Current Status and Future Possibilities.
    Park K; Otte A
    Annu Rev Biomed Eng; 2019 Jun; 21():61-84. PubMed ID: 30786212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.